{"title": "Anti-TB drugs can increase risk of TB re-infection", "title_detail": {"type": "text/plain", "language": null, "base": "https://www.sciencedaily.com/rss/health_medicine/immune_system.xml", "value": "Anti-TB drugs can increase risk of TB re-infection"}, "links": [{"rel": "alternate", "type": "text/html", "href": "https://www.sciencedaily.com/releases/2019/03/190322163334.htm"}], "link": "https://www.sciencedaily.com/releases/2019/03/190322163334.htm", "summary": "Current treatments for tuberculosis (TB) are very effective in controlling TB infection caused by Mycobacterium tuberculosis (Mtb). They don't, however, always prevent reinfection. Why this happens is one of the long-standing questions in TB research. A team of scientists may have found the answer... in the gut.", "summary_detail": {"type": "text/html", "language": null, "base": "https://www.sciencedaily.com/rss/health_medicine/immune_system.xml", "value": "Current treatments for tuberculosis (TB) are very effective in controlling TB infection caused by Mycobacterium tuberculosis (Mtb). They don't, however, always prevent reinfection. Why this happens is one of the long-standing questions in TB research. A team of scientists may have found the answer... in the gut."}, "published": "Fri, 22 Mar 2019 16:33:34 EDT", "published_parsed": [2019, 3, 22, 20, 33, 34, 4, 81, 0], "id": "https://www.sciencedaily.com/releases/2019/03/190322163334.htm", "guidislink": false}